Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.96% | 9.29% | 8.90% | 6.10% | 5.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.96% | 9.29% | 8.90% | 6.10% | 5.08% |
| Cost of Revenue | 13.95% | 10.32% | 9.08% | 4.74% | 3.83% |
| Gross Profit | 6.61% | 8.79% | 8.82% | 6.76% | 5.68% |
| SG&A Expenses | 9.78% | 8.62% | 8.26% | 5.80% | 4.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 39.48% | -242.53% | -444.69% | -1,297.92% | -579.55% |
| Total Operating Expenses | 12.39% | 9.43% | 8.41% | 4.98% | 3.70% |
| Operating Income | 0.14% | 8.90% | 10.24% | 9.15% | 8.79% |
| Income Before Tax | -34.58% | -31.43% | -43.08% | -2.21% | -2.05% |
| Income Tax Expenses | -67.86% | -38.85% | -25.96% | 32.83% | 91.38% |
| Earnings from Continuing Operations | -11.45% | -27.56% | -50.38% | -14.53% | -26.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.45% | -27.56% | -50.38% | -14.53% | -26.86% |
| EBIT | 0.14% | 8.90% | 10.24% | 9.15% | 8.79% |
| EBITDA | 3.04% | 9.25% | 10.48% | 9.24% | 8.59% |
| EPS Basic | -11.42% | -27.56% | -50.42% | -14.68% | -27.03% |
| Normalized Basic EPS | 10.93% | 23.95% | 12.56% | 4.87% | 6.70% |
| EPS Diluted | -11.41% | -27.57% | -50.44% | -14.65% | -27.02% |
| Normalized Diluted EPS | 10.93% | 23.95% | 12.59% | 4.91% | 6.78% |
| Average Basic Shares Outstanding | -0.04% | 0.00% | 0.09% | 0.19% | 0.24% |
| Average Diluted Shares Outstanding | -0.04% | 0.00% | 0.06% | 0.15% | 0.16% |
| Dividend Per Share | 0.85% | 12.22% | 12.22% | 9.03% | 9.03% |
| Payout Ratio | 0.27% | 0.55% | 1.28% | 0.32% | 0.44% |